Other ranitidine products will be removed from the market

In a recent press release announces the FDA that ranitidine products (Zantac)) will be withdrawn from the market due to the contaminationknown as N-Nitrosodimethylamine (NDMA).

Recall of Sandoz ranitidine capsules following detection of an impurity

Vänliga frågor och svar – Fragen und Antwort

Rückruf von einigen ranitidinhaltigen Arzneimitteln aufgrund von NDMA